1. Home
  2. ESNT vs TECH Comparison

ESNT vs TECH Comparison

Compare ESNT & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Essent Group Ltd.

ESNT

Essent Group Ltd.

HOLD

Current Price

$65.23

Market Cap

5.9B

Sector

Finance

ML Signal

HOLD

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$58.84

Market Cap

9.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESNT
TECH
Founded
2008
1976
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
9.2B
IPO Year
2013
1989

Fundamental Metrics

Financial Performance
Metric
ESNT
TECH
Price
$65.23
$58.84
Analyst Decision
Buy
Strong Buy
Analyst Count
5
14
Target Price
$68.00
$71.23
AVG Volume (30 Days)
640.5K
1.6M
Earning Date
02-13-2026
02-04-2026
Dividend Yield
1.91%
0.54%
EPS Growth
N/A
N/A
EPS
6.87
0.49
Revenue
$1,263,558,000.00
$1,216,732,000.00
Revenue This Year
$3.87
$2.33
Revenue Next Year
$1.55
$7.05
P/E Ratio
$9.46
$120.82
Revenue Growth
2.04
3.85
52 Week Low
$51.61
$46.01
52 Week High
$67.09
$79.28

Technical Indicators

Market Signals
Indicator
ESNT
TECH
Relative Strength Index (RSI) 57.17 45.70
Support Level $65.41 $58.54
Resistance Level $66.11 $59.64
Average True Range (ATR) 0.89 1.45
MACD -0.07 0.04
Stochastic Oscillator 46.29 49.84

Price Performance

Historical Comparison
ESNT
TECH

About ESNT Essent Group Ltd.

Essent Group Ltd serves the housing finance industry by providing private mortgage insurance, reinsurance, risk management products, title insurance, and settlement services to mortgage lenders, borrowers, and investors to support homeownership. It provides credit protection to lenders and mortgage investors by covering a portion of the unpaid principal balance of a mortgage and certain related expenses in the event of a default. By providing capital to mitigate mortgage credit risk, the company allows lenders to make additional mortgage financing available to prospective homeowners.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: